Page 34 - TD-3-4

Tumor Discovery Expert consensus of NUT carcinoma

51. Bouchard C, Dittrich O, Kiermaier A, et al. Regulation of TTF1. Pathology. 2021;53(5):663-666.
cyclin D2 gene expression by the Myc/Max/Mad network: doi: 10.1016/j.pathol.2020.09.027
Myc-dependent TRRAP recruitment and histone acetylation
at the cyclin D2 promoter. Genes Dev. 2001;15(16):2042-2047. 62. Yang F, Shen D, Shi J. Primary renal NUT carcinoma
identified by next-generation sequencing: A case report and
doi: 10.1101/gad.907901
literature review. Int J Clin Exp Pathol. 2021;14(5):662-669.
52. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 63. Alcasid NJ, Banks KC, Sun A, Velotta JB. Case report on the
3q27-29, encodes multiple products with transactivating,
death-inducing, and dominant-negative activities. Mol Cell. role of aggressive palliative surgery in lung NUT carcinoma
1998;2(3):305-316. after induction chemoimmunotherapy. Int J Surg Case
Rep. 2023;105:108015.
doi: 10.1016/s1097-2765(00)80275-0
doi: 10.1016/j.ijscr.2023.108015
53. Durall RT, Huang J, Wojenski L, et al. The BRD4-NUT fusion 64. Giridhar P, Mallick S, Kashyap L, Rath GK. Patterns of care
alone drives malignant transformation of NUT carcinoma.
Cancer Res. 2023;83(23):3846-3860. and impact of prognostic factors in the outcome of NUT
midline carcinoma: A systematic review and individual
doi: 10.1158/0008-5472.CAN-23-2545 patient data analysis of 119 cases. Eur Arch Otorhinolaryngol.
54. McEvoy CR, Holliday H, Thio N, et al. A MXI1-NUTM1 2018;275(3):815-821.
fusion protein with MYC-like activity suggests a novel doi: 10.1007/s00405-018-4882-y
oncogenic mechanism in a subset of NUTM1-rearranged
tumors. Lab Invest. 2021;101(1):26-37. 65. Huang WP, Gao G, Qiu YK, et al. Multimodality imaging
and treatment of paranasal sinuses nuclear protein in
doi: 10.1038/s41374-020-00484-3 testis carcinoma: A case report. World J Clin Cases.
55. Boer JM, Valsecchi MG, Hormann FM, et al. Favorable 2022;10(33):12395-12403.
outcome of NUTM -rearranged infant and pediatric B cell doi: 10.12998/wjcc.v10.i33.12395
1
precursor acute lymphoblastic leukemia in a collaborative
international study. Leukemia. 2021;35(10):2978-2982. 66. Higashino M, Kinoshita I, Kurisu Y, et al. Supraglottic NUT
carcinoma: A case report and literature review. Case Rep
doi: 10.1038/s41375-021-01333-y Oncol. 2022;15(3):980-987.
56. Chau NG, Hurwitz S, Mitchell CM, et al. Intensive treatment doi: 10.1159/000526815
and survival outcomes in NUT midline carcinoma of the
head and neck. Cancer. 2016;122(23):3632-3640. 67. Jiang J, Ren Y, Xu C, Liu X. NUT midline carcinoma as
a primary lung tumor treated with anlotinib combined
doi: 10.1002/cncr.30242 with palliative radiotherapy: A case report. Diagn Pathol.
57. Zhou J, Duan M, Jiao Q, et al. Primary thyroid NUT 2022;17(1):4.
carcinoma with high PD-L1 expression and novel massive doi: 10.1186/s13000-021-01188-y
IGKV gene fusions: A case report with treatment implications
and literature review. Front Oncol. 2021;11:778296. 68. Muramatsu J, Takada K, Sugita S, et al. Complete response
induced by concurrent chemoradiotherapy in a patient with
doi: 10.3389/fonc.2021.778296 NUT carcinoma. Intern Med. 2022;61(8):1299-1304.
58. Carter T, Crook M, Murch A, et al. Incidence of NUT doi: 10.2169/internalmedicine.7741-21
carcinoma in Western Australia from 1989 to 2014: A review
of pediatric and adolescent cases from perth children’s 69. Sopfe J, Greffe B, Treece AL. Metastatic NUT midline
hospital. BMC Cancer. 2021;21(1):740. carcinoma treated with aggressive neoadjuvant
chemotherapy, radiation, and resection: A case report
doi: 10.1186/s12885-021-08432-0 and review of the literature. J Pediatr Hematol Oncol.
59. Costa BA, Maraveyas A, Wilkoff MH, et al. Primary 2021;43(1):e73-e75.
pulmonary NUT carcinoma: Case illustration and updated doi: 10.1097/MPH.0000000000001860
review of literature. Clin Lung Cancer. 2022;23(4):e296-e300.
70. Vulsteke C, Lurquin E, Debiec-Rychter M, et al. First
doi: 10.1016/j.cllc.2022.03.001 evidence of treatment efficacy in metastatic carcinoma of the
60. Li W, Chastain K. NUT midline carcinoma with leukemic parotid gland with BRD /NUT translocation. J Chemother.
4
presentation mimicking CD34-positive acute leukemia. 2016;28(3):242-246.
Blood. 2018;132(4):456.
doi: 10.1179/1973947815Y.0000000046
doi: 10.1182/blood-2017-07-796268 71. Luo J, Sanchez M, Lee E, et al. Initial chemotherapy for
61. Prall O, Thio N, Yerneni S, Kumar B, McEvoy CR. A NUT locally advanced and metastatic NUT carcinoma. J Thorac
carcinoma lacking squamous differentiation and expressing Oncol. 2023;19:829-838.

Volume 3 Issue 4 (2024) 26 doi: 10.36922/td.4904